Company Description
Semnur Pharmaceuticals (OTC Link: SMNR) is a publicly traded company.
SMNR stock has declined 60.0% over the past year. Shares last traded at $8.00.
On a trailing twelve-month basis, Semnur Pharmaceuticals reported net income of -$160.4M and diluted earnings per share of $-0.78.
This page provides a comprehensive overview of SMNR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Semnur Pharmaceuticals (SMNR) stock last traded at $8.00. Over the past 12 months, the stock has lost 60.0%.
Latest News
SEC Filings
Semnur Pharmaceuticals has filed 5 recent SEC filings, including 2 Form 8-K, 1 Form 10-K, 1 Form S-1/A, 1 Form 10-Q. The most recent filing was submitted on March 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SMNR SEC filings →
Financial Highlights
operating income reached -$160.4M, and net income was -$160.4M. Diluted earnings per share stood at $-0.78. The company generated -$5.9M in operating cash flow. With a current ratio of 0.06, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in Semnur Pharmaceuticals (SMNR) currently stands at 1.5 thousand shares, down 6.3% from the previous reporting period, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment. The 6.6 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Semnur Pharmaceuticals (SMNR) currently stands at 6.6 days, down 60.5% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has decreased 33.1% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 6.6 to 1000.0 days.